Yes does seem to have some good early results for them and yes you are right, we do have the jump in terms of time.
This one again is a stem cell related treatment. We have discussed the general approach here before, a while ago.
As I and others have said in the past, it is one to watch and it will no doubt become potential competition as they and others get it refined? It can be patient specific and in the past there have been mixed results with some experiencing AE's and other side effects. A quick review of their initial results does look like they got a good percentage of their patients experiencing positive results in the specific plantar fasciitis area (area where the bone of the heel meets the toes).
They have a lot more work to do and will involve time, our solution has the benefit of scale (not tailored made for each specific patient, less (very little) chance of rejection by the body etc) along with it's long safety record (though in a different route of administration hence the trials).
Keep your eyes opened!
DYOR too.
- Forums
- ASX - By Stock
- PAR
- research reports and media
research reports and media, page-1282
-
- There are more pages in this discussion • 3,147 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAR (ASX) to my watchlist
(20min delay)
|
|||||
Last
19.0¢ |
Change
-0.010(5.00%) |
Mkt cap ! $66.54M |
Open | High | Low | Value | Volume |
20.0¢ | 21.0¢ | 19.0¢ | $203.4K | 1.019M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
14 | 387930 | 19.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
20.5¢ | 65468 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
13 | 384246 | 0.190 |
3 | 57000 | 0.185 |
8 | 194873 | 0.180 |
6 | 140904 | 0.175 |
7 | 595605 | 0.170 |
Price($) | Vol. | No. |
---|---|---|
0.205 | 65468 | 2 |
0.210 | 25992 | 3 |
0.215 | 30000 | 1 |
0.220 | 27066 | 4 |
0.225 | 21604 | 2 |
Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |